[1] BhattHB,SmithRJ, 2015.Fatty liver disease in diabetes mellitus,Hepatobiliary Surg Nutr 4 101 -8
[2] SrinivasanK,ViswanadB,AsratL,KaulC, 2005.Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening,Pharmacol Res 52 313 -20
[3] ArulB,KothaiR,ChristinaA, 2010.Hypoglycemic activity of casearia esculenta roxb in normal and diabetic albino rats,Iran J Pharm Res 47 -51
[4] RanksPakistan,W., 2008.7th on diabetes prevalence list,The Nation -
[5] CusiK., 2010.The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes,Curr Diab Rep 10 306 -15
[6] SungKC,KimSH, 2011.Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes,J Clin Endocrinol Metab 96 1093 -7
[7] UtzschneiderKM,KahnSE, 2006.The role of insulin resistance in nonalcoholic fatty liver disease,J Clin Endocrinol Metab 91 4753 -61
[8] SongR, 2016.Mechanism of metformin: A tale of two sites,Diabetes Care 39 187 -9
[9] ZafarM,NaqviSN, 2010.Effects of STZ-Induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: A comparative study,Int J Morphol 28 1 -
[10] MasonT,ChanB,El-BahraniB,GohT,GuptaN,GambleJ, 2002.The effect of chronic insulin delivery via the intraperitoneal versus the subcutaneous route on hepatic triglyceride secretion rate in streptozotocin diabetic rats,Atherosclerosis 161 345 -52
[11] LinHZ,YangSQ,ChuckareeC,KuhajdaF,RonnetG,DiehlAM, 2000.Metformin reverses fatty liver disease in obese, leptindeficient mice,Nat Med 6 998 -1003
[12] TessariP,TiengoA, 2008.Metformin treatment of rats with dietinduced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver,Acta Diabetol 45 143 -5
[13] KleinerDE,BruntEM,Van NattaM,BehlingC,ContosMJ,CummingsOW, 2005.Design and validation of a histological scoring system for nonalcoholic fatty liver disease,Hepatology 41 1313 -21
[14] KnodellRG,IshakKG,BlackWC,ChenTS,CraigR,KaplowitzN, 1981.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis,Hepatology 1 431 -5
[15] IshakK,BaptistaA,BianchiL,CalleaF,De GrooteJ,GudatF, 1995.Histological grading and staging of chronic hepatitis,J Hepatol 22 696 -9
[16] KriskaA,DelahantyL,EdelsteinS,AmodeiN,ChadwickJ,CopelandK, 2013.Sedentary behaviour and physical activity in youth with recent onset of type 2 diabetes,Pediatrics 131 e850 -e6
[17] KahnBB,FlierJS, 2000.Obesity and insulin resistance,J Clin Invest 106 473 -81
[18] FaehD,MinehiraK,SchwarzJM,PeriasamyR,ParkS, 2005.Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men,Diabetes 54 1907 -13
[19] LingvayI,RaskinP,SzczepaniakLS, 2007.Effect of insulinmetformin combination on hepatic steatosis in patients with type 2 diabetes,J Diabetes Complications 21 137 -42
[20] MazzaA,FruciB,GarinisGA,GiulianoS,MalaguarneraR,BelfioreA, 2012.The role of metformin in the management of NAFLD,Exp Diabetes Res -
[21] LingvayI,RoeED,DuongJ,LeonardD,SzczepaniakLS, 2012.Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes,J Investig Med 60 1059 -63
[22] FurlongNJ,HulmeSA,O'brienSV,HardyKJ, 2002.Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy,Diabetes Care 25 1685 -90
[23] JaberLA,NowakSN,SlaughterRR, 2002.Insulin-metformin combination therapy in obese patients with type 2 diabetes,J Clin Pharmacol New Drugs 42 89 -94